SK pharmteco

We are thrilled to announce that SK pharmteco's Audrey Greenberg will be speaking at Phacilitate Women in Advanced Therapies Global virtual event on July 10-11. Tune in tomorrow at 2 PM EDT to hear Audrey's valuable insights during the session, "Trailblazing Women in Biotech: Insights from Successful Female Founders & CEOs." WIAT Global is a digital event offering 24 hours of exclusive content tailored for industry leaders and innovators in the life sciences. This groundbreaking event brings together empowering women and their allies at the forefront of biotech, pharmaceuticals, and academia to drive progress in advanced therapies. Register for the event and explore the full agenda here: https://lnkd.in/eg9BW2eb #WIAT2024 #LifeSciences #WomenInLeadership #AdvancedTherapies #CGT #WomenInSTEM #Biotech #Pharmaceuticals #Innovation

Happy Independence Day from all of us at SK pharmteco! 🎆 Wishing everyone a safe and joyous Fourth of July filled with pride and gratitude. 

Oligonucleotides play a critical role in today's biotechnology and medical research, driving advancements in diagnostics, therapeutics, and genetic analysis. In a recent interview with Rizwan Chaudhrey, SK pharmteco's Marc J Jacob, Ph.D. shares our latest capabilities in oligonucleotides.   #biotech #biomanufacturing #advancedtherapies

At SK pharmteco, our viral vector manufacturing experts are dedicated to your projects, ensuring exceptional services and collaboration! For your cell or gene therapy needs, we provide comprehensive services from process development to commercial batches, for a seamless transition from innovation to market. Our commitment to quality and scalability ensures that we deliver impactful solutions globally, with manufacturing capabilities in Europe and the US.   Learn more and contact our experts: https://lnkd.in/eGS9emSW #ViralVector #CellandGeneTherapy #BioManufacturing

The rapid growth in cell and gene therapies has changed the landscape for CDMOs, and the need for all-inclusive, cost-effective, and low-risk alternatives to traditional manufacturing models is on the rise. Outsourcing is becoming a key strategy for many companies, enabling them to leverage specialized expertise, advanced technologies, and scalable solutions. This approach not only accelerates time-to-market but also enhances overall production quality and compliance. SK pharmteco stands at the forefront of this transformation with its state-of-the-art capabilities in cell and gene therapy manufacturing, offering comprehensive solutions that meet the highest standards of quality and innovation. Read more how CDMOs are elevating the CGT manufacturing game: https://lnkd.in/eskCwpq5 BioProcess International #CellandGeneTherapy #CDMO #biomanufacturing #CGT

Join us tomorrow as Audrey Greenberg provides the welcoming remarks at the Philadelphia Life Sciences Conference! This event will bring together industry leaders and experts from Philadelphia's life sciences sector as they discuss groundbreaking research, innovative technologies, funding strategies, regulatory landscapes, and more. This is a unique opportunity to delve into the topics crucial to the life sciences market. 📅 Date: Thursday, June 27, 2024 🕗 Time: 8:00 AM EDT 📍 Location: Live! Casino & Hotel, Philadelphia, PA Don't miss out—register now! Tickets are still available here: https://lnkd.in/e57D_dGv Bisnow #lifesciences #philadelphiabusiness

Revolutionize your #GeneTherapy manufacturing process with our cutting-edge Flexible Drug Product Vial Filler! SK pharmteco’s gloveless isolator technology ensures aseptic conditions and single-use capability, safeguarding against contamination and preserving product sterility. Discover the future of precision and flexibility in Gene Therapy production, contact us today to learn more! https://lnkd.in/egVykeW7 #AsepticTechnology #GeneTherapy #SterileProduct #BioTech

Organized jointly by SK pharmteco and ART-TG, the inaugural MOMENTUM in Cell and Gene Therapy convened on June 19, 2024, in Evry-Courcouronnes, France, bringing together world-renowned scientists, industry leaders, suppliers, CDMOs, students, and other stakeholders. This event marked a significant milestone in advancing the future of cell and gene therapies. The event opened with a keynote address by Dr. Bruce Levine, renowned for his pioneering work in genetically engineered T-cells, captivated attendees with insights into translating innovative therapies into transformative patient outcomes. Dr. Michael Hudecek, from Wurtzburg University opened the afternoon session with a keynote address that delved into the latest advancements in engineered T-cell therapies, highlighting achievements within European networks. Closing the symposium, Audrey Greenberg examined the thriving biotech ecosystem of Philadelphia as a model for accelerating the global delivery of cell and gene therapies. She emphasized the critical part that universities play in driving innovation, as well as the replicability of successful clusters and strategies to enhance collaboration and drive funding to support the growth in the cell and gene therapy space. #CellTherapy #GeneTherapy #MOMENTUM2024 #BiotechInnovation

📣 Exciting News from SK pharmteco! We are thrilled to announce that Audrey Greenberg and Matthew Farabaugh have been honored as 2024 Philadelphia Titan 100 recipients! 🏆🎉 The TITAN 100 program celebrates Philadelphia’s Top 100 CEOs & C-level executives who exemplify exceptional leadership, vision, and passion in their industries. Audrey and Matthew's dedication and achievements have significantly contributed to SK pharmteco’s success and leadership in the life science sector. Additionally, we are proud to announce that Audrey has also been honored as a Titan 100 Hall of Fame inductee! The Titan 100 Hall of Fame is comprised of an elite group of entrepreneurs who are pillars of our community, embodying leadership and impact. Audrey's induction into the Titan 100 Hall of Fame is a testament to her consistent dedication to being a leader in the biotech space and Philadelphia community over the past three years. Together, the 2024 Philadelphia Titan 100 and their companies employ nearly 140,000 individuals and generate over $14.6 billion in annual revenues. This esteemed group will be featured in a prestigious Titan 100 book and highlighted online, showcasing their impactful contributions to Philadelphia’s business community. They will be honored at the annual awards ceremony on September 19th, 2024. Join us in congratulating Audrey and Matthew on this well-deserved recognition as a 2024 Philadelphia Titan 100 and Audrey's Hall of Fame award! 🌟 We look forward to celebrating their continued success and leadership at SK pharmteco. #Titan100 #PhiladelphiaLeadership #BusinessExcellence

As the advanced therapies sector evolves, the need for adaptable and scalable platform solutions to reduce costs and expand patient access is becoming increasingly crucial. From viral vector manufacturing and cell therapy processing to plasmid production and related analytics, we face numerous challenges in building resilient platforms for cell and gene therapies. SK pharmteco's innovative LentiSure™ and AAVelocity™ technologies simplify these processes, speeding up the development and production of advanced therapies. Learn more by watching the video or downloading the poster: https://lnkd.in/gbTpuDsR #AAV #AnalyticalServices #AdvancedTherapies #CDMO